| Identification | Back Directory | [Name]
2-[[4-[2-[(4-Chloro-2-fluorophenyl)methoxy]phenyl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]-1H-benzimidazole-6-carboxylic acid | [CAS]
2784590-83-4 | [Synonyms]
2-[[4-[2-[(4-Chloro-2-fluorophenyl)methoxy]phenyl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]-1H-benzimidazole-6-carboxylic acid | [Molecular Formula]
C31H31ClFN3O4 | [MOL File]
2784590-83-4.mol | [Molecular Weight]
564.05 |
| Chemical Properties | Back Directory | [Boiling point ]
740.7±60.0 °C(Predicted) | [density ]
1.39±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | [form ]
Solid | [pka]
3.98±0.30(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
GLP-1 receptor agonist 11 (compound 3) is an agonist of GLP Receptor. GLP-1 receptor agonist 11 can be used in the study of diseases such as diabetes and non-alc. fatty liver disease[1]. | [References]
[1] Li Ben, et al. Preparation of piperazine-imidazole containing GLP-1R receptor agonist compounds and application thereof. China, CN114591308 A. 2022-06-07. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|